Study Stopped
Send in by another researcher. This is terminated to avoid two identical studies
New Method for Real-time Detection of Tissue Ischemia
ISCALERT
1 other identifier
observational
N/A
1 country
1
Brief Summary
This is a prospective, single arm, open, single centre clinical investigation designed to examine the feasibility and safety of the IscAlert™ device in patients scheduled for limb (arm/leg) surgery with tourniquet. IscAlert is measuring carbon dioxide in muscular and subcutaneous tissue. IscAlert is inserted into normal muscle and subcutaneous tissue in ischemic (operated limb with a tourniquet) and non-ischemic limb (non-operated limb).After the tourniquet is inflated, ischemia develops in the muscles and subcutaneous tissue. This will result in an increase in carbon dioxide, which will be detected by the sensor on the operated extremity, while the sensor on the non-operated will show normal values. After releasing the tourniquet cuff, the muscle will be reperfused and the carbon dioxide level is expected to decrease into normal levels. 50 number of patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the operating room, but in 25 of the patients, IscAlert™ will be inserted for 72 hours in the operated extremity after the end of surgery. After this, the sensors are removed.250 Devices is planned to be used in this clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2020
CompletedStudy Start
First participant enrolled
May 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2021
CompletedFirst Posted
Study publicly available on registry
May 19, 2021
CompletedMay 24, 2021
May 1, 2021
Same day
August 10, 2020
May 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tissue carbon dioxide level
Tissue carbon dioxide level (kPa) during insertion period
72 hours
Secondary Outcomes (8)
Bleeding
72 hours
Infection
1 week
Arterial carbon dioxide level
2 hours
Arterial lactate level
2 hours
Arterial pH level
2 hours
- +3 more secondary outcomes
Study Arms (2)
Group 1
Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed immediately after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.
Group 2
Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed 72 hours after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.
Interventions
3 IscAlert sensors in the limb undergoing surgery and two control sensors in the opposite limb are inserted and carbon dioxide is measured continuously.
Eligibility Criteria
Patients who need limb surgery with tourniquet cuff
You may qualify if:
- Patients must be scheduled for orthopedic limb surgery with planned use of tourniquet.
- Subject must be ≥ 18 years
- Able to give written signed informed consent
- Tourniquet planned to be used \> 30 minutes
You may not qualify if:
- Sign of inflammation/infection, hematoma, and traumatized tissue at insertion site
- Chronic use of anticoagulants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- European Commissioncollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Magne Røkkum, Md, Ph.d
Oslo University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 10, 2020
First Posted
May 19, 2021
Study Start
May 14, 2021
Primary Completion
May 14, 2021
Study Completion
May 14, 2021
Last Updated
May 24, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share
No plan to share IPD to other researchers